Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol

  • US 6,884,439 B2
  • Filed: 01/16/2004
  • Issued: 04/26/2005
  • Est. Priority Date: 11/10/1997
  • Status: Expired due to Term
First Claim
Patent Images

1. A method for treating acute promyelocytic leukemia in a human comprising administering a therapeutically effective dosage amount of about 0.15 mg/kg arsenic trioxide once per day.

View all claims

    Thank you for your feedback